Stoboclo
Denosumab-bmwo · CELLTRION USA, Inc.
PRESCRIPTION ONLY (USA)Stoboclo ingredients
| Active ingredient | Strength |
|---|---|
| Denosumab | 60 mg/mL |
What Stoboclo is used for
Stoboclo is a specialist medicine (rank ligand inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Stoboclo
- Generic name
- Denosumab-bmwo
- Made by
- CELLTRION USA, Inc.
- Forms
- Injection
- Given
- Subcutaneous
- Drug class
- RANK Ligand Inhibitor
- FDA approval
- Biologic licence (BLA) BLA761404
- On the US market since
- 2025
Official information
- Stoboclo prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Denosumab-bmwo)
In India
- Denosumab: 11 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Stoboclo?
Stoboclo (Denosumab-bmwo) is a specialist medicine made by CELLTRION USA, Inc., approved by the US FDA.
What are the ingredients of Stoboclo?
Stoboclo contains Denosumab (60 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA